The paper studies the dynamics of firm growth and firm size distributions in the pharmaceutical industry from 1950 to 2003 and in the biotechnology industry from the early 1980's to 2003. Growth dynamics are studied in the context of how the size composition of firms changes, how innovation patterns (patents) change, as well as locational decisions of firms (NJ vs. California). Results suggest that Gibrat's law (random growth) does not hold for the majority of the period under observation, and that the growth advantage of small pharma firms increases after the 1980's as the process of innovation becomes more 'guided' and scale intensive and as small firm innovation becomes more 'persistent'. Furthermore, at the end of the 1970's a 'bimodal' firm size distribution emerges in the pharmaceutical industry precisely when a new division of labor between large and small firms sets in. We find that firms located in California are smaller, faster growing and more innovative than those in NJ.
Download Info
To our knowledge, this item is not available for
download. To find whether it is available, there are three
options:
1. Check below under "Related research" whether another version of this item is available online.
2. Check on the provider's web page
whether it is in fact available.
3. Perform a search for a similarly titled item that would be
available.
Publisher Info
Paper provided by The Open University, Faculty of Social Sciences, Department of Economics in its series Open Discussion Papers in Economics with number
63.